Edesa Biotech, Inc. Common Shares (EDSA) Dividend History

Company News

• Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital

  Dr. Pardeep Nijhawan and Velan Capital have updated their beneficial ownership of securities in Edesa Biotech, Inc. Dr. Nijhawan acquired 100 Series B-1 Convertible Preferred Shares, while Velan Capital acquired 568 Series B-1 Convertible Preferred Shares, both for investment purposes.

  GlobeNewswire Inc.
• Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

  Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 84.3% to $0.2678 in pre-market trading after declining 9% on Tuesday. Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 28.6% to $10.93 in pre-market trading. C4 Therapeutics, Inc. (NASDAQ: CCCC) gained 28.6% to $3.01 in pre-market trading after the company announced positive data from CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Stifel upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12. Mynaric AG (NASDAQ: MYNA) shares surged 16.9% to $5.60 in pre-market trading after the company received a $33 million order from Northrop Grumman. MyMD Pharmaceuticals, Inc. (NASDAQ:

  Benzinga

  Featured Companies: ATNF BURU CCCC CISO INAB RSLS SFWL VSME WLGS ZJYL